British Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 28, 2025
Background
and
Purpose
Psoriasis
is
a
multisystem
inflammatory
disease
with
significant
impact
on
quality
of
life.
Stellera
chamaejasme
,
medicinal
plant
used
in
traditional
Chinese
medicine,
shows
promise
for
the
treatment
psoriasis.
We
identified
diterpenoids
S.
including
new
compound,
stellchamain
A
(SA,
1
),
notable
antipsoriasis
properties.
This
study
explored
effects
SA
psoriasis
to
determine
mechanisms
underlying
therapeutic
efficacy
.
Experimental
Approach
Compounds
isolated
by
column
chromatography
were
structurally
using
NMR
spectroscopy.
The
IL‐17A‐treated
HaCaT
cell
viability
apoptosis
assessed
CCK‐8
TUNEL
assays.
In
vivo
anti‐psoriasis
activity
was
evaluated
mouse
model
imiquimod
(IMQ)‐induced
Network
pharmacology,
surface
plasmon
resonance
(SPR),
drug
affinity
responsive
target
stability
(DARTS),
cellular
thermal
shift
assays
(CETSA)
elucidated
interactions
between
targets.
Key
Results
from
along
nine
known
analogues
(
2
–
10
).
vivo,
reduced
IMQ‐induced
epidermal
thickness,
hyperkeratosis,
perivascular
infiltration.
pharmacology
indicated
that
may
function
via
interleukin
IL‐17A/STAT1/S100A9
pathway.
results
SPR
molecular
docking
showed
binds
STAT1
K
D
value
9.24
nM.
DARTS
CETSA
analyses
confirmed
direct
relevant
interaction
STAT1.
Conclusion
Implications
modulates
immunological
microenvironment
treat
targeting
axis,
representing
potential
other
IL‐17A‐mediated
skin
disorders.
British Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 20, 2025
Plasmalemma
vesicle-associated
protein
(PLVAP)
regulates
transcytosis
in
vascular
endothelial
cells.
PLVAP
expression
is
increased
pathological
conditions,
such
as
diabetic
retinopathy.
P2X7
receptor
antagonists
have
been
shown
to
preserve
blood-retinal
barrier
(BRB)
integrity.
Here,
we
tested
the
hypothesis
that
tightly
linked
activity,
leading
breakdown
of
BRB
an
vitro
model
We
integrated
network
approaches
with
retinopathy
using
primary
human
retinal
microvascular
cells
(HRMECs).
Cells
were
treated
a
antagonist,
JNJ47965567,
and
several
genes
predicted
belong
signalling
assessed.
Levels
localisation
PLVAP,
VE-cadherin
zonula
occludens-1
(ZO-1)
HRMECs
evaluated.
In
vivo,
effects
JNJ47965567
on
retinas
mice
High
levels
glucose
HRMECs,
which
was
blocked
by
JNJ47965567.
Furthermore,
preserved
ZO-1.
choroidal
vasculature
mice,
immunostaining
increased,
compared
non-diabetic
mice.
This
increase
significantly
attenuated
treatment
CONCLUSIONS
AND
IMPLICATIONS:
study
showed
important
component
complex
gene
regulatory
network,
including
mediating
pathophysiology
The
antagonist
good
pharmacodynamic
profile,
suggesting
this
approach
could
be
value
British Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 13, 2025
Background
and
Purpose
Amyotrophic
lateral
sclerosis
(ALS)
is
a
devastating
neurodegenerative
disease
with
limited
treatment
options.
ALS
pathogenesis
involves
intricate
processes
within
motor
neurons,
characterized
by
dysregulated
Ca
2+
influx
buffering
in
early
ALS‐affected
neurones.
This
study
proposes
the
modulation
of
ryanodine
receptors
(RyRs),
key
mediators
intracellular
,
as
therapeutic
target.
Experimental
Approach
A
novel
class
FKBP12
ligands
that
show
activity
cytosolic
calcium
modulators
through
stabilizing
RyR
channel
activity,
were
tested
superoxide
dismutase
1
(SOD1)
G93A
mouse
model
ALS.
Different
outcomes
used
to
assess
efficacy,
including
electrophysiology,
histopathology,
neuromuscular
function
survival.
Key
Results
Among
ligands,
MP‐010
was
chosen
for
its
central
nervous
system
availability
favourable
vitro
pharmaco‐toxicological
profile.
Chronic
administration
SOD1
mice
produced
preservation
nerve
conduction,
61‐mg·kg
−1
dose
significantly
delaying
onset
impairment.
accompanied
improved
coordination,
increased
innervated
endplates
significant
neurones
spinal
cord
treated
mice.
Notably,
extended
lifespan
an
average
10
days
compared
vehicle.
Conclusions
Implications
particularly
MP‐010,
exhibit
promising
neuroprotective
effects
ALS,
highlighting
their
potential
agents.
Further
investigations
into
molecular
mechanisms
clinical
translatability
these
compounds
are
needed
application
treatment.
British Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 16, 2025
Abstract
Background
and
Purpose
Sex‐dependent
vascular
effects
of
transient
receptor
potential
(TRP)
channels
sex
dimorphism
in
migraine
are
not
yet
fully
characterized.
We
investigated
the
differential
vasoactive
TRP
ankyrin
1
(TRPA1),
melastatin
3
(TRPM3)
vanilloid
(TRPV1)
channels,
their
pharmacological
mechanism(s),
localization
expression
human
isolated
blood
vessels.
Experimental
Approach
Agonist
responses
to
cinnamaldehyde
pregnenolone
sulfate
(PregS,
TRPM3)
or
capsaicin
were
analysed
using
wire
myography
segments
coronary
(HCAs)
middle
meningeal
(HMMAs)
arteries
from
men
women.
The
mechanisms
involved
these
antagonists/blockers/inhibitors:
HC‐030031
isosakuranetin
(TRPM3),
capsazepine
(TRPV1),
olcegepant
(calcitonin
gene‐related
peptide
[CGRP]
receptor),
L‐NAME
(nitric
oxide
synthase
[NOS]),
indomethacin
(cyclooxygenase
[COX]),
TRAM‐34
+
apamin
(K
channels)
MK‐801
(
N
‐methyl‐
d
‐aspartate
[NMDA]
receptor).
Fluorescence
microscopy,
quantitative
polymerase
chain
reaction
(qPCR),
western
blotting
performed
investigate
location
expression,
respectively.
Key
Results
In
HCAs
HMMAs,
(i)
capsaicin‐induced
relaxation
remained
unchanged
after
above‐mentioned
antagonists/blockers/inhibitors
(ii)
cinnamaldehyde‐induced
was
blocked
by
olcegepant.
PregS‐induced
maximal
significantly
enhanced
females
compared
with
males
inhibited
isosakuranetin,
L‐NAME.
TRPM3
mRNA
protein
along
NMDA
levels,
higher
than
males.
Conclusion
Implications
Modulation
tone
HMMAs
activation
is
sex‐dependent,
likely
involving
receptors.
This
represents
a
new
therapeutic
direction,
targeting
its
related
cardiovascular
events.
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(15), P. 2413 - 2428
Published: May 21, 2024
Cystic
fibrosis
(CF)
patients
are
living
longer
and
healthier
due
to
improved
treatments,
e.g.
cystic
transmembrane
conductance
regulator
(CFTR)
modulator
therapy
elexacaftor/tezacaftor/ivacaftor
(ETI),
with
treatment
possibly
occurring
in
pregnancy.
The
risk
of
ETI
foetuses
remain
unknown.
Thus
the
effect
maternally
administered
on
foetal
genetic
structural
development
was
investigated.
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(22), P. 4450 - 4490
Published: Sept. 3, 2024
Viroporins
possess
important
potential
as
antiviral
targets
due
to
their
critical
roles
during
virus
life
cycles,
spanning
from
entry
egress.
Although
the
amantadine
M2
viroporin
of
influenza
A
virus,
successful
progression
other
inhibitors
into
clinical
use
remains
challenging.
These
challenges
relate
in
varying
proportions
a
lack
reliable
full‐length
3D‐structures,
difficulties
functionally
characterising
individual
viroporins,
and
absence
verifiable
direct
binding
between
inhibitor
viroporin.
This
review
offers
perspectives
help
overcome
these
challenges.
We
provide
comprehensive
overview
family,
including
structural
functional
features,
highlighting
moldability
energy
landscapes
actions.
To
advance
field,
we
suggest
list
best
practices
aspire
towards
unambiguous
identification
characterisation,
along
with
considerations
pitfalls.
Finally,
present
current
future
scenarios
of,
prospects
for,
targeting
drugs.
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(13), P. 2070 - 2084
Published: March 25, 2024
Background
and
Purpose
Kratom
is
a
preparation
from
Mitragyna
speciosa
,
which
used
as
natural
drug
for
many
purposes
around
the
world.
However,
an
overdose
of
may
cause
addiction‐like
problems
including
aversive
withdrawal
states
resulting
in
cognitive
impairments
via
unknown
mechanisms.
Its
main
psychoactive
alkaloid
mitragynine,
showing
opioid‐like
properties.
Experimental
Approach
Here,
we
analysed
neuropharmacological
effects
mitragynine
compared
with
morphine
rats
searched
pharmacological
treatment
option
that
reverse
occurring
deficits
usually
aggravate
withdrawal.
Key
Results
We
found
14‐day
(1–10
mg·kg
−1
·day
)
caused
dose‐dependent
behavioural
signs
resembling
those
(5
10
also
induced
passive
avoidance
task.
Mitragynine
not
only
reduced
hippocampal
field
excitatory
postsynaptic
potential
(fEPSP)
amplitudes
basal
synaptic
transmission
long‐term
potentiation
(LTP)
but
epigenetic
markers,
such
histone
H3K9
H4K12
expression.
At
same
time,
it
up‐regulates
HDAC2
Targeting
adaptations
HDAC
inhibitor,
SAHA
reversed
on
dysregulation,
input/output
curves,
paired‐pulse
facilitation,
LTP
attenuated
deficit.
amplified
Conclusion
Implications
The
data
this
work
show
changes
expression
downstream
plasticity
explain
morphine,
behaviours
impairments.
Thus,
provide
new
approach
Kratom/mitragynine
addiction.
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(17), P. 3282 - 3299
Published: May 14, 2024
Many
medications
taste
intensely
bitter.
The
innate
aversion
to
bitterness
affects
medical
compliance,
especially
in
children.
There
is
a
clear
need
develop
bitter
blockers
suppress
the
of
vital
medications.
Bitter
mediated
by
TAS2R
receptors.
Because
different
pharmaceutical
compounds
activate
distinct
sets
TAS2Rs,
targeting
specific
receptors
may
only
for
certain,
but
not
all,
bitter-tasting
compounds.
Alternative
strategies
are
needed
identify
universal
that
will
improve
acceptance
every
medication.
Taste
cells
mouth
transmit
signals
afferent
gustatory
nerve
fibres
through
release
ATP,
which
activates
nerve-expressed
purine
P2X2/P2X3.
We
hypothesized
blocking
transmission
with
P2X2/P2X3
inhibitors
(e.g.
5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidine-2,4-diamine
[AF-353])
would
reduce
all
and
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(18), P. 3445 - 3461
Published: May 21, 2024
Background
and
Purpose
Fibromyalgia
is
a
complex
clinical
disorder
with
an
unknown
aetiology,
characterized
by
generalized
pain
co‐morbid
symptoms
such
as
anxiety
depression.
An
imbalance
of
oxidants
antioxidants
proposed
to
play
pivotal
role
in
the
pathogenesis
fibromyalgia
symptoms.
However,
precise
mechanisms
which
oxidative
stress
contributes
fibromyalgia‐induced
remain
unclear.
The
transient
receptor
potential
ankyrin
1
(TRPA1)
channel,
known
both
sensor
sensor,
has
been
implicated
various
painful
conditions.
Experimental
Approach
feed‐forward
mechanism
that
implicates
reactive
oxygen
species
(ROS)
driven
TRPA1
was
investigated
reserpine‐induced
model
C57BL/6J
mice
employing
pharmacological
interventions
genetic
approaches.
Key
Results
Reserpine‐treated
developed
pain‐like
behaviours
(mechanical/cold
hypersensitivity)
early
anxiety‐depressive‐like
disorders,
accompanied
increased
levels
markers
sciatic
nerve
tissues.
These
effects
were
not
observed
upon
blockade
or
global
deletion
channel
macrophage
depletion.
Furthermore,
we
demonstrated
selective
silencing
Schwann
cells
reduced
neuroinflammation
(NADPH
oxidase
1‐dependent
ROS
generation
increase
nerve)
attenuated
fibromyalgia‐like
behaviours.
Conclusion
Implications
Activated
expressing
promote
intracellular
pathway
culminating
release
recruitment
macrophages
mouse
nerve.
cellular
molecular
events
sustain
mechanical
cold
hypersensitivity
reserpine‐evoked
model.
Targeting
channels
on
could
offer
novel
therapeutic
approach
for
managing
fibromyalgia‐related
British Journal of Pharmacology,
Journal Year:
2024,
Volume and Issue:
181(18), P. 3503 - 3526
Published: May 23, 2024
Abstract
Background
and
Purpose
Excitotoxicity
due
to
mitochondrial
calcium
(Ca
2+
)
overloading
can
trigger
neuronal
cell
death
in
a
variety
of
pathologies.
Inhibiting
the
uniporter
(MCU)
has
been
proposed
as
therapeutic
avenue
prevent
overloading.
Ru265
(ClRu(NH
3
4
(μ‐N)Ru(NH
Cl]Cl
is
cell‐permeable
inhibitor
with
nanomolar
affinity.
reduces
sensorimotor
deficits
models
ischemic
stroke.
However,
use
limited
by
induction
seizure‐like
behaviours.
Experimental
Approach
We
examined
effect
on
synaptic
function
acute
brain
slices
hippocampal
neuron
cultures
derived
from
mice,
control
where
MCU
expression
was
genetically
abrogated.
Key
Results
decreased
evoked
responses
calyx
terminals
induced
spontaneous
action
potential
firing
both
terminal
postsynaptic
principal
cell.
Recordings
presynaptic
Ca
currents
suggested
that
blocks
P/Q
type
channel,
confirmed
inhibition
cells
exogenously
expressing
channel.
Measurements
K
+
further
revealed
blocked
KCNQ
current,
leading
increased
membrane
excitability,
underlying
spiking.
imaging
neurons
showed
synchronized,
high‐amplitude
events,
recapitulating
activity
seen
vivo
.
Importantly,
ablation
did
not
suppress
Ru265‐induced
increases
seizures.
Conclusions
Implications
Our
findings
provide
mechanistic
explanation
for
pro‐convulsant
effects
suggest
counter
screening
assays
based
measurement
channel
identify
safe
inhibitors.